TrialJournal of managed care & specialty pharmacy2022

Changes in acute headache medication use and health care resource utilization: Results from a randomized, double-blind, placebo-controlled clinical trial evaluating galcanezumab in adults with treatment-resistant migraine (CONQUER).

Anna Ambrosini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.